Veru Inc. (VERU) stock
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
$2.14+0.06 (+2.88%)
Close on Nov 17, 2026Market cap $36.49MP/E –Yield –
Veru cash
Cash and short-term investments held at the end of each period.
Veru's cash was $23.88M at Jun 30, 2026. For fiscal 2025 it was $15.79M, down 36.6% from the year before. Over ten years it grew 14.0% a year on average. The highest annual figure on record is $24.92M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $15.79M | -36.6% |
| FY2024 | Sep 30, 2024 | $24.92M | +158.9% |
| FY2023 | Sep 30, 2023 | $9.63M | +156.0% |
| FY2018 | Sep 30, 2018 | $3.76M | +14.7% |
| FY2017 | Sep 30, 2017 | $3.28M | +37.4% |
| FY2016 | Sep 30, 2016 | $2.39M | -41.9% |
| FY2015 | Sep 30, 2015 | $4.11M | -29.2% |
| FY2014 | Sep 30, 2014 | $5.80M | -35.0% |
| FY2013 | Sep 30, 2013 | $8.92M | +68.5% |
| FY2012 | Sep 30, 2012 | $5.30M | +24.5% |
| FY2011 | Sep 30, 2011 | $4.25M | +45.5% |
| FY2010 | Sep 30, 2010 | $2.92M | +4.0% |
| FY2009 | Sep 30, 2009 | $2.81M | +46.2% |
| FY2008 | Sep 30, 2008 | $1.92M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $23.88M | +59.1% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $27.60M | +37.9% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $32.99M | +24.0% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $15.79M | -36.6% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $15.01M | -48.5% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $20.02M | +108.0% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $26.61M | +231.0% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $24.92M | +322.6% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $29.15M | +224.6% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $9.63M | +156.0% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $8.04M | +44.1% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $5.90M | -34.3% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $8.98M | +151.4% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $3.76M | +14.7% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $5.58M | +108.8% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $8.97M | +622.7% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $3.57M | +2.5% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $3.28M | +37.4% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $2.67M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $1.24M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $3.49M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $2.39M | – |
See a number that looks wrong?